ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Prophylactic Cranial Irradiation Improved Survival in Metastatic SCLC

Prophylactic Cranial Irradiation Improved Survival in Metastatic SCLC

 

The role of prophylactic cranial irradiation (PCI) in patients with extensive-stage small-cell lung cancer (SCLC) remains controversial, with previous studies reporting conflicting results.

In this video, Sonam Sharma, MD, of the University of Pennsylvania, Philadelphia, discusses results of a National Cancer Database study that looked at metastatic SCLC patients without brain metastases who received either chemotherapy (n = 3,784) or chemotherapy plus PCI (n = 473).

Sharma presented the results of the study (abstract 11) at the 2017 Multidisciplinary Thoracic Cancers Symposium, held March 16–18 in San Francisco.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.